Global Specimen Validity Testing Market Analysis 2024: Size Forecast and Growth Prospects

The specimen validity testing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Specimen Validity Testing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The specimen validity testing market size has grown strongly in recent years. It will grow from $3.37 billion in 2023 to $3.68 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%.  The growth in the historic period can be attributed to increasing drug adoption, increased drug screening, stringent regulations, increased alcohol use, and integration of point-of-care testing.

The specimen validity testing market size is expected to see strong growth in the next few years. It will grow to $5.27 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%.  The growth in the forecast period can be attributed to rising demand for workplace drug testing, growing adoption of oral fluid testing, rise in research and development operations, rising usage of SVTand expanding applications in pain management. Major trends in the forecast period include technological advancements, integration of artificial intelligence for result interpretation, product innovations, increasing partnerships, and the development of portable testing devices for on-the-go monitoring.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report

Scope Of Specimen Validity Testing Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Specimen Validity Testing Market Overview

Market Drivers –
The increased drug abuse is expected to propel the growth of the specimen validity testing market going forward. Drug abuse refers to the customary, excessive, or inappropriate use of legal or illegal substances for non-medical purposes. Drug abuse is increasing due to several interconnected factors, such as the opioid habit, developing mental health issues, barriers to treatment and support resources, and cultural depictions. SVT methods are developed to identify the presence of impurities and compounds by examining several parameters such as pH, specific gravity, creatinine content, and temperature. For instance, in October 2023, according to the Office for Health Improvement and Disparities, a UK-based government department, adult contacts with drug and alcohol programs rose from April 2021 to March 2022, totaling 0.29 million interactions, up from 0.28 million the year prior. Additionally, in May 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, opioid overdose deaths in the USA increased by 15% from 70,029 in 2020 to 80,816 in 2021. Therefore, the increased drug abuse is expected to propel the growth of the specimen validity testing market.

Market Trends –
Major companies operating in the specimen validity testing market are developing innovative products such as high-resolution urine drug testing profiles, to sustain their position in the market. A high-resolution urine drug testing profile is a sophisticated testing method with advanced analytical techniques. For instance, in July 2022, Mayo Clinic Laboratories, a US-based medical laboratory, launched a data-driven urine drug testing (UDT) profile to equip physicians with the necessary information for managing patients with addiction to common substances like prescription opioids, alcohol, marijuana, and nicotine. This new addiction medicine monitoring profile (Mayo ID ADMPU) aligns with the American Society of Addiction Medicine’s guidelines. It offers enhanced sensitivity and specificity to identify parent drugs and metabolites from various drug classes, including opioids, benzodiazepines, stimulants, and PCP. The profile utilizes high-resolution, accurate mass spectrometry for targeted and immunoassay testing for specific substances, providing comprehensive and clinically relevant information for healthcare providers.

The specimen validity testing market covered in this report is segmented –
1) By Product And Service: Products, Service
2) By Testing Type: Laboratory Testing, Rapid Or Point-Of-Care Testing
3) By End-User: Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Criminal Justice And Law Enforcement Agencies, Other End-Users

Get an inside scoop of the specimen validity testing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp

Regional Insights –
North America was the largest region in the specimen validity testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the specimen validity testing market are  Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers , Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd

Table of Contents
1. Executive Summary
2. Specimen Validity Testing Market Report Structure
3. Specimen Validity Testing Market Trends And Strategies
4. Specimen Validity Testing Market – Macro Economic Scenario
5. Specimen Validity Testing Market Size And Growth
…..
27. Specimen Validity Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model